HC Wainwright & Co. reiterated coverage on Checkpoint Therapeutics with a new price target

1/25/22 9:58:19 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

HC Wainwright & Co. reiterated coverage of Checkpoint Therapeutics with a rating of Buy and set a new price target of $26.00 from $17.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$CKPT

Date	Price Target	Rating	Analyst
1/13/2025	$9.00	Buy	D. Boral Capital
7/14/2022	$7.00	Buy	B. Riley Securities
1/25/2022	$17.00 → $26.00	Buy	HC Wainwright & Co.